Intrahepatic Cholangiocarcinoma  >>  alvocidib (DSP-2033)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
alvocidib (DSP-2033) / Sumitomo Pharma
NCT00047307: Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

Completed
1
46
US
alvocidib, FLAVO, flavopiridol, HMR 1275, L-868275, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT, laboratory biomarker analysis
National Cancer Institute (NCI)
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
08/08
 

Download Options